Table 2.
Short-term (30-day) mortality | ||||||
---|---|---|---|---|---|---|
115.00–133.99 | 134.00–137.00 | 137.01–140.99 | 141.00–142.99 | 143.00–175.00 | p trend | |
Person Observations | 7,318 | 20,895 | 29,928 | 14,711 | 9,525 | |
Deaths | 320 | 424 | 419 | 223 | 403 | |
Person-Observation-years | 261.25 | 852.89 | 1,294.66 | 655.97 | 411.11 | |
Deaths per 100 POYs | 122.49 | 49.71 | 32.36 | 34.00 | 98.03 | |
Crude model | 3.37 (2.85–3.99) | 1.50 (1.29–1.74) | 1.00 (ref) | 1.03 (0.85–1.23) | 2.49 (2.12–2.92) | <0.0001 |
Age adjusted model | 3.45 (2.92–4.07) | 1.54 (1.32–1.79) | 1.00 (ref) | 0.99 (0.83–1.19) | 2.35 (2.00–2.75) | <0.0001 |
Multivariable modelǂ | 2.96 (2.48–3.53) | 1.47 (1.25–1.71) | 1.00 (ref) | 1.02 (0.85–1.24) | 2.46 (2.08–2.90) | <0.0001 |
Long-term (>30 day) mortality | ||||||
Person Observations | 51,865 | 179,463 | 272,156 | 137,405 | 85,410 | |
Deaths | 3,371 | 7,189 | 8,767 | 4,538 | 4,579 | |
Person-Observation-years | 8,838.89 | 39,633.90 | 70,704.47 | 38,380.01 | 23,460.67 | |
Deaths per 100 POYs | 38.14 | 18.14 | 12.40 | 11.82 | 19.52 | |
Crude model | 2.79 (2.68–2.91) | 1.43 (1.38–1.48) | 1.00 (ref) | 0.95 (0.92–0.99) | 1.45 (1.39–1.50) | <0.0001 |
Age adjusted model | 2.90 (2.78–3.02) | 1.48 (1.44–1.53) | 1.00 (ref) | 0.92 (0.88–0.95) | 1.35 (1.30–1.40) | <0.0001 |
Multivariable modelǂ | 2.48 (2.38–2.60) | 1.38 (1.34–1.43) | 1.00 (ref) | 0.95 (0.91–0.98) | 1.40 (1.35–1.46) | <0.0001 |
The 137.01–140.99 mmol/L is the reference serum sodium category. Missing values are as follows: eGFR = 780, serum potassium=40, race=2,883. POY= person-observation years.
Adjusted for age, sex, race, body mass index, estimated glomerular filtration rate, serum potassium, hypertension, hyperlipidemia, coronary artery disease, atrial fibrillation, diabetes mellitus type II, chronic obstructive pulmonary disease, anemia, angiotensin converting enzyme inhibitor/angiotensin receptor blocker prescription, beta blocker prescription, and calcium channel blocker prescription.